RFA Plus Carrizumab vs Carrizumab Alone for HCC
Clinical trial NCT04150744 · RECRUITING
Trial details
- NCT number
- NCT04150744
- Sponsor
- Second Affiliated Hospital, Zhejiang University, School of Medicine
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-08-01
- Primary completion
- 2025-12-30
- Enrollment
- 120
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.